Alan Meds vs Try Ageless
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alan Meds
Best for budget-conscious shoppersStarting at $99/mo
Try Ageless
Best for Cost-sensitive patients seeking the lowest-tier compounded GLP-1 prices with a LegitScript-verifiable telehealth platform, especially those who want non-injectable oral forms (drops or troche) for needle-aversion and accept the weaker oral-compounded evidence base.Starting at $119/mo
Side-by-Side Comparison
| Feature | Alan Meds | Try Ageless |
|---|---|---|
| Overall Score | ✓7.7/10 | 6.8/10 |
| Starting Price | ✓$99/mo | $119/mo |
| Editorial Rating | ✓3.9 ★ /5 | 3.4 ★ /5 |
| Features | 5 features | ✓7 features |
| States Available | ✓46 | 0 |
| Compounded | ✓ Yes | ✓ Yes |
| Brand Name | — | — |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alan Meds
Pros
- ✓Aggressively low monthly pricing
- ✓Both semaglutide and tirzepatide available
- ✓Compounded GLP-1 access
- ✓Multiple administration formats
Cons
- ✗Limited public information on program details
Try Ageless
Pros
- ✓LegitScript Certified with visible ID (123956) — verifiable signal vs badge-only competitors
- ✓THREE compounded form factors offered: injection, troche, sublingual drops — broadest DTC form-factor range in the WLR directory
- ✓Verbatim FDA compounded-medication disclaimer published (uncommon transparency)
- ✓Among the lowest advertised introductory prices — semaglutide injection $119/mo is one of the cheapest tier-1 prices we track
- ✓Delaware corporate address disclosed (Suite 305, 131 Continental Dr, Newark, DE 19713)
- ✓Longevity + metabolic health positioning aligns with the broader DTC longevity-medicine trend
Cons
- ✗Introductory pricing (-17% to -30% discounts) — refill/maintenance pricing not disclosed publicly; common DTC pattern is price escalation post-introductory tier
- ✗Pharmacy partner NOT named (only 'state-licensed pharmacies' generic framing)
- ✗States-served list NOT enumerated — 'Availability depends on your state' framing
- ✗Named medical director NOT disclosed
- ✗503A vs 503B compounding designation NOT specified
- ✗Compounded oral forms (drops, troche) have weaker evidence base vs injectable — no STEP/SURMOUNT-equivalent oral compounded RCTs
- ✗Corporate legal entity (LLC/Inc/PC) NOT explicitly disclosed (Newark DE address suggests DE LLC, but designation absent)
- ✗Broad longevity-platform scope may dilute weight-loss-specific clinical focus vs specialist competitors
Our Verdict
Alan Meds edges out Try Ageless with a higher overall score of 7.7/10 and is particularly strong for budget-conscious shoppers. Try Ageless remains a solid alternative, especially if you're looking for Cost-sensitive patients seeking the lowest-tier compounded GLP-1 prices with a LegitScript-verifiable telehealth platform, especially those who want non-injectable oral forms (drops or troche) for needle-aversion and accept the weaker oral-compounded evidence base..
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.